Circulating and Placental Endoglin Concentrations in Pregnancies Complicated by Intrauterine Growth Restriction and Preeclampsia
- 6 May 2008
- Vol. 29 (6) , 555-563
- https://doi.org/10.1016/j.placenta.2008.03.006
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Endoglin in angiogenesis and vascular diseasesAngiogenesis, 2008
- Severe Intrauterine Growth Restriction Pregnancies Have Increased Placental Endoglin Levels: Hypoxic Regulation via Transforming Growth Factor-β3The American Journal of Pathology, 2008
- Placental Productions and Expressions of Soluble Endoglin, Soluble fms-Like Tyrosine Kinase Receptor-1, and Placental Growth Factor in Normal and Preeclamptic PregnanciesJournal of Clinical Endocrinology & Metabolism, 2008
- A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonateThe Journal of Maternal-Fetal & Neonatal Medicine, 2008
- Novel biochemical pathways of endoglin in vascular cell physiologyJournal of Cellular Biochemistry, 2007
- Uric Acid Is as Important as Proteinuria in Identifying Fetal Risk in Women With Gestational HypertensionHypertension, 2005
- PreeclampsiaHypertension, 2005
- Intrauterine growth restriction increases morbidity and mortality among premature neonatesAmerican Journal of Obstetrics and Gynecology, 2004
- Hypoxic Induction of Endoglin via Mitogen-Activated Protein Kinases in Mouse Brain Microvascular Endothelial CellsStroke, 2003
- Identification of a Natural Soluble Form of the Vascular Endothelial Growth Factor Receptor, FLT-1, and Its Heterodimerization with KDRBiochemical and Biophysical Research Communications, 1996